US Broker Ratings

Encompass Health Corporation (EHC) Stock Analysis: A 34% Potential Upside with Strong Buy Ratings

Encompass Health Corporation (NYSE: EHC), a leading player in the healthcare sector, is capturing investor attention with its robust performance metrics and an enticing 34.15% potential upside. As the largest..

DexCom, Inc. (DXCM) Stock Analysis: Strong Buy Ratings and a 35.78% Potential Upside

DexCom, Inc. (NASDAQ: DXCM), a frontrunner in the healthcare sector, has been making waves in the medical devices industry with its innovative continuous glucose monitoring (CGM) systems. This San Diego-based..

Waystar Holding Corp. (WAY) Stock Analysis: Strong Buy Ratings and 39.53% Potential Upside

Waystar Holding Corp. (WAY) has garnered significant attention from investors, and with good reason. This healthcare information services company, which specializes in cloud-based software solutions for healthcare payments, is positioned..

Koninklijke Philips N.V. (PHG) Stock Analysis: Unveiling a 13.6% Potential Upside in the Healthcare Sector

For investors eyeing opportunities in the healthcare sector, Koninklijke Philips N.V. (PHG) presents an intriguing proposition. Operating as a health technology giant, Philips continues to innovate across its Diagnosis &..

DaVita Inc. (DVA) Stock Analysis: Navigating Growth with a 64.85% Return on Equity

DaVita Inc. (NYSE: DVA) stands as a prominent player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $9.89 billion, DaVita is a..

HCA Healthcare, Inc. (HCA) Stock Analysis: Strong Buy Ratings and 11.20% Potential Upside

HCA Healthcare, Inc. (NYSE: HCA), a stalwart in the medical care facilities industry, continues to draw investor attention with its robust market position and promising financial metrics. With a market..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Navigating Growth in the Medical Devices Sector

Smith & Nephew SNATS, Inc. (NYSE: SNN), a prominent player in the healthcare sector, particularly within the medical devices industry, presents a compelling case for investors. With a market capitalization..

BeOne Medicines Ltd. (ONC) Stock Analysis: Exploring a 26% Potential Upside in the Biotech Sector

For investors hunting for promising opportunities in the healthcare sector, BeOne Medicines Ltd. (ONC) stands out with a compelling growth narrative and significant potential upside. Based in Switzerland, this biotechnology..

The Cigna Group (CI) Stock Analysis: Exploring a 21.45% Upside Potential

The Cigna Group (NYSE: CI), a leading player in the healthcare plans industry, presents an intriguing opportunity for investors with its robust market position and compelling growth metrics. Headquartered in..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Exploring a 26% Upside Potential with Pioneering Medical Innovations

Intuitive Surgical, Inc. (NASDAQ: ISRG), a leading name in the healthcare sector, particularly in the medical instruments and supplies industry, has been a cornerstone in advancing minimally invasive surgical procedures...

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Exploring a 23% Upside Potential

Thermo Fisher Scientific Inc. (NYSE: TMO), a titan in the healthcare sector specializing in diagnostics and research, presents a compelling investment opportunity with a significant potential upside. With a market..

Tempus AI, Inc. (TEM) Stock Analysis: Navigating a 29.59% Potential Upside in the Healthcare Information Sector

Tempus AI, Inc. (NASDAQ: TEM) is catching the attention of investors interested in the intersection of healthcare and technology. With a market capitalization of $10.02 billion, this healthcare technology company..

Royalty Pharma plc (RPRX): Investor Outlook with a Promising 3.56% Potential Upside

Royalty Pharma plc (NASDAQ: RPRX) stands out in the biotechnology sector as a unique player focused on acquiring biopharmaceutical royalties and funding innovation. With a market capitalization of $29.64 billion,..

Ascendis Pharma A/S (ASND) Stock Report: A Promising Biotech with 20.95% Potential Upside

Ascendis Pharma A/S (NASDAQ: ASND) stands out in the biotechnology sector with its innovative approach to addressing unmet medical needs through TransCon-based therapies. Headquartered in Hellerup, Denmark, this biopharmaceutical company..

Centene Corporation (CNC) Stock Analysis: Exploring a 13.58% Potential Upside in Healthcare Plans

Centene Corporation (NYSE: CNC), a prominent player in the healthcare plans industry, presents an intriguing opportunity for investors seeking exposure to the healthcare sector. With a market capitalization of $18.77..

Solventum Corporation (SOLV) Stock Analysis: A 20% Upside Potential Amidst Mixed Signals

Solventum Corporation (NYSE: SOLV), a prominent player in the healthcare sector, is drawing significant attention from investors with its potential upside of 20.13%. Despite facing some challenges, such as a..

Penumbra, Inc. (PEN) Stock Analysis: A Healthcare Contender with 10% Upside Potential

For investors seeking opportunities in the healthcare sector, Penumbra, Inc. (NYSE: PEN) presents a compelling case. As a key player in the medical devices industry, Penumbra has established itself with..

Teva Pharmaceutical Industries (TEVA): Exploring Growth Potential with a 17.85% Upside

Teva Pharmaceutical Industries (NYSE: TEVA), a leading player in the healthcare sector, has long been synonymous with innovation in drug manufacturing. As a key player in the specialty and generic..

Elevance Health, Inc. (ELV) Stock Analysis: Uncovering a 17.13% Potential Upside in the Healthcare Sector

Elevance Health, Inc. (NYSE: ELV), a prominent player in the healthcare plans industry, presents an intriguing opportunity for investors seeking stability and growth within the healthcare sector. With a market..

Quest Diagnostics (DGX) Stock Analysis: A 11.88% Potential Upside with Strong Buy Ratings

Quest Diagnostics Incorporated (NYSE: DGX) is a prominent player in the healthcare sector, specializing in diagnostic testing and services. With a market capitalization of $21.59 billion, Quest Diagnostics is a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds